Interestingly, the CRISPR screen further revealed that ALDH9A1, a key enzyme that catalyzes gamma-aminobutyraldehyde to GABA [78], showed significant sgRNA depletion but not sgRNA enrichment in cancer cells cocultured with NK cells (Supplementary Fig. S2D and E). Here, ALDH9A1 is linked to cancer.